0001415889-24-004704.txt : 20240221
0001415889-24-004704.hdr.sgml : 20240221
20240221211050
ACCESSION NUMBER: 0001415889-24-004704
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240220
FILED AS OF DATE: 20240221
DATE AS OF CHANGE: 20240221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Horn Kinney
CENTRAL INDEX KEY: 0001831215
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39580
FILM NUMBER: 24662017
MAIL ADDRESS:
STREET 1: C/O OLEMA PHARMACEUTICALS, INC.
STREET 2: 512 2ND STREET, 4TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Immunome Inc.
CENTRAL INDEX KEY: 0001472012
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 770694340
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 665 STOCKTON DRIVE
STREET 2: SUITE 300
CITY: EXTON
STATE: PA
ZIP: 19341
BUSINESS PHONE: 610-321-3700
MAIL ADDRESS:
STREET 1: 665 STOCKTON DRIVE
STREET 2: SUITE 300
CITY: EXTON
STATE: PA
ZIP: 19341
4
1
form4-02222024_020242.xml
X0508
4
2024-02-20
0001472012
Immunome Inc.
IMNM
0001831215
Horn Kinney
C/O IMMUNOME, INC.
665 STOCKTON DRIVE, SUITE 300
EXTON
PA
19341
false
true
false
false
CHIEF BUSINESS OFFICER
0
Stock option (right to buy)
23
2024-02-20
4
A
0
300000
0
A
2034-02-19
Common Stock
300000
300000
D
25% of the shares subject to the options vest on February 12, 2025, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.
/s/ Sandra Stoneman, Attorney-in-Fact
2024-02-21